Dive into the crucial aspects of biotech commercialization with Kirsten Detrick on Season 2, Episode 2 of the Cut The Chat Podcast. Learn why early commercialization strategies matter and discover key insights from a seasoned biotech executive.

Tune in to Cut The Chat’s Season 2, Episode 1 as Seuss+ CEO Sabine Hutchison explores with Stephanie Oestreich of MIF the intersections of investment, scientific breakthroughs, and the quest for a Myeloma cure. Dive into a conversation about the challenges and triumphs of specialty funds and the impact of strategic investments on clinical trials.